BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2673831)

  • 21. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
    Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
    Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
    Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment.
    Yang H; Acker JP; Cabuhat M; Letcher B; Larratt L; McGann LE
    Bone Marrow Transplant; 2005 May; 35(9):881-7. PubMed ID: 15778729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation.
    Rowley SD; Piantadosi S; Santos GW
    Bone Marrow Transplant; 1989 Sep; 4(5):553-8. PubMed ID: 2790333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
    Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
    Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation.
    Bacigalupo A; Piaggio G; Podesta M; Figari O; Benvenuto F; Sogno G; Tedone E; Raffo MR; Grassia L; Ferrero R
    Bone Marrow Transplant; 1995 Feb; 15(2):221-6. PubMed ID: 7773210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation].
    Mayer J; Korístek Z; Pospísil Z; Vásová I; Adam Z; Hájek R; Krejcí M; Král Z; Navrátil M; Vorlícek J; Bourková L; Matýsková M; Adler J; Vinklárková J; Klabusay M; Koutná I; Hoffová V; Schmitzová D; Janovská E
    Cas Lek Cesk; 1999 Mar; 138(6):170-7. PubMed ID: 10510531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohammed R
    Exp Hematol; 1997 Jun; 25(6):471-7. PubMed ID: 9197323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.
    Bolwell BJ; Goormastic M; Yanssens T; Dannley R; Baucco P; Fishleder A
    Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose cytotoxic therapy with autologous bone marrow or peripheral blood progenitor cell transplantation in malignant lymphomas.
    Cucuianu A; D'Hondt L; Collignon J; Verhulst D; Deprijck B; Chatelain C; Doyen C; Bosly A
    Rom J Intern Med; 1995; 33(3-4):211-25. PubMed ID: 8646194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
    Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
    Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
    Schots R; Van Riet I; Damiaens S; Flament J; Lacor P; Staelens Y; Steenssens L; van Camp B; De Waele M
    Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients.
    Barbot C; Rice A; Vanès I; Mahon FX; Jazwiec B; Reiffers J
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):325-31. PubMed ID: 7971254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma.
    Brandwein JM; Callum J; Sutcliffe SB; Scott JG; Keating A
    Bone Marrow Transplant; 1990 Nov; 6(5):291-4. PubMed ID: 2291991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Autografts of blood cells at various stages].
    Castaigne S; Dal Cortivo L; Leverger G; Miclea JM; Lepage E; Benbunan M; Gerota J; Degos L; Boiron M
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):69-73. PubMed ID: 2898752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
    Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
    Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of cyclophosphamide on the bone marrow hematopoiesis in the mouse].
    Xie RF
    Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):435-7. PubMed ID: 3836845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients.
    Yoo KH; Lee SH; Kim HJ; Sung KW; Jung HL; Cho EJ; Park HK; Kim HA; Koo HH
    Bone Marrow Transplant; 2007 May; 39(9):515-21. PubMed ID: 17334379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.